Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored Regimens of Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C
NCT00540345Phase 4Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Oct 2006
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Started Oct 2006; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00540345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540345.